vs
Cytek Biosciences, Inc.（CTKB）与RBB Bancorp（RBB）财务数据对比。点击上方公司名可切换其他公司
Cytek Biosciences, Inc.的季度营收约是RBB Bancorp的1.9倍（$62.1M vs $32.3M），RBB Bancorp净利率更高（31.5% vs -70.9%，领先102.4%），RBB Bancorp同比增速更快（12.6% vs 8.1%），RBB Bancorp自由现金流更多（$42.6M vs $-1.8M），过去两年Cytek Biosciences, Inc.的营收复合增速更高（17.7% vs 7.0%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
RBB银行控股公司是总部位于美国的金融控股集团，旗下核心主体为皇家商业银行，主要服务亚裔社群、中小微企业、不动产投资者及零售客户，提供商业信贷、储蓄存款、财富管理等多元金融服务，业务覆盖美国沿海核心都会区。
CTKB vs RBB — 直观对比
营收规模更大
CTKB
是对方的1.9倍
$32.3M
营收增速更快
RBB
高出4.5%
8.1%
净利率更高
RBB
高出102.4%
-70.9%
自由现金流更多
RBB
多$44.4M
$-1.8M
两年增速更快
CTKB
近两年复合增速
7.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $32.3M |
| 净利润 | $-44.1M | $10.2M |
| 毛利率 | 52.9% | — |
| 营业利润率 | -9.0% | 39.5% |
| 净利率 | -70.9% | 31.5% |
| 营收同比 | 8.1% | 12.6% |
| 净利润同比 | -557.1% | 132.1% |
| 每股收益（稀释后） | — | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBRBB
| Q4 25 | $62.1M | $32.3M | ||
| Q3 25 | $52.3M | $32.6M | ||
| Q2 25 | $45.6M | $35.8M | ||
| Q1 25 | $41.5M | $28.5M | ||
| Q4 24 | $57.5M | $28.7M | ||
| Q3 24 | $51.5M | $30.3M | ||
| Q2 24 | $46.6M | $27.5M | ||
| Q1 24 | $44.9M | $28.2M |
净利润CTKBRBB
| Q4 25 | $-44.1M | $10.2M | ||
| Q3 25 | $-5.5M | $10.1M | ||
| Q2 25 | $-5.6M | $9.3M | ||
| Q1 25 | $-11.4M | $2.3M | ||
| Q4 24 | $9.6M | $4.4M | ||
| Q3 24 | $941.0K | $7.0M | ||
| Q2 24 | $-10.4M | $7.2M | ||
| Q1 24 | $-6.2M | $8.0M |
毛利率CTKBRBB
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
营业利润率CTKBRBB
| Q4 25 | -9.0% | 39.5% | ||
| Q3 25 | -17.6% | 40.7% | ||
| Q2 25 | -23.3% | 36.1% | ||
| Q1 25 | -36.1% | 11.2% | ||
| Q4 24 | 5.2% | 17.6% | ||
| Q3 24 | -8.2% | 31.6% | ||
| Q2 24 | -18.3% | 35.6% | ||
| Q1 24 | -23.9% | 39.9% |
净利率CTKBRBB
| Q4 25 | -70.9% | 31.5% | ||
| Q3 25 | -10.5% | 31.2% | ||
| Q2 25 | -12.2% | 26.1% | ||
| Q1 25 | -27.5% | 8.0% | ||
| Q4 24 | 16.8% | 15.3% | ||
| Q3 24 | 1.8% | 23.1% | ||
| Q2 24 | -22.4% | 26.4% | ||
| Q1 24 | -13.8% | 28.4% |
每股收益（稀释后）CTKBRBB
| Q4 25 | — | $0.59 | ||
| Q3 25 | — | $0.59 | ||
| Q2 25 | — | $0.52 | ||
| Q1 25 | — | $0.13 | ||
| Q4 24 | — | $0.26 | ||
| Q3 24 | — | $0.39 | ||
| Q2 24 | — | $0.39 | ||
| Q1 24 | — | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $212.3M |
| 总债务越低越好 | — | $119.9M |
| 股东权益账面价值 | $341.7M | $523.4M |
| 总资产 | $461.5M | $4.2B |
| 负债/权益比越低杠杆越低 | — | 0.23× |
8季度趋势，按日历期对齐
现金及短期投资CTKBRBB
| Q4 25 | $90.9M | $212.3M | ||
| Q3 25 | $93.3M | $234.9M | ||
| Q2 25 | $75.5M | $191.9M | ||
| Q1 25 | $95.3M | $238.8M | ||
| Q4 24 | $98.7M | $257.7M | ||
| Q3 24 | $162.3M | $349.4M | ||
| Q2 24 | $177.9M | $252.8M | ||
| Q1 24 | $168.8M | — |
总债务CTKBRBB
| Q4 25 | — | $119.9M | ||
| Q3 25 | — | $119.8M | ||
| Q2 25 | — | $119.7M | ||
| Q1 25 | — | $119.6M | ||
| Q4 24 | — | $119.5M | ||
| Q3 24 | — | $119.4M | ||
| Q2 24 | — | $119.3M | ||
| Q1 24 | — | $119.2M |
股东权益CTKBRBB
| Q4 25 | $341.7M | $523.4M | ||
| Q3 25 | $378.6M | $514.3M | ||
| Q2 25 | $377.6M | $517.7M | ||
| Q1 25 | $379.6M | $510.3M | ||
| Q4 24 | $395.7M | $507.9M | ||
| Q3 24 | $385.5M | $509.7M | ||
| Q2 24 | $389.1M | $511.3M | ||
| Q1 24 | $392.6M | $514.0M |
总资产CTKBRBB
| Q4 25 | $461.5M | $4.2B | ||
| Q3 25 | $494.9M | $4.2B | ||
| Q2 25 | $493.3M | $4.1B | ||
| Q1 25 | $482.6M | $4.0B | ||
| Q4 24 | $499.5M | $4.0B | ||
| Q3 24 | $491.2M | $4.0B | ||
| Q2 24 | $483.7M | $3.9B | ||
| Q1 24 | $492.1M | $3.9B |
负债/权益比CTKBRBB
| Q4 25 | — | 0.23× | ||
| Q3 25 | — | 0.23× | ||
| Q2 25 | — | 0.23× | ||
| Q1 25 | — | 0.23× | ||
| Q4 24 | — | 0.24× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $43.4M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $42.6M |
| 自由现金流率自由现金流/营收 | -2.9% | 131.8% |
| 资本支出强度资本支出/营收 | 1.6% | 2.5% |
| 现金转化率经营现金流/净利润 | — | 4.26× |
| 过去12个月自由现金流最近4个季度 | $-8.8M | $73.5M |
8季度趋势，按日历期对齐
经营现金流CTKBRBB
| Q4 25 | $-771.0K | $43.4M | ||
| Q3 25 | $-3.9M | $2.1M | ||
| Q2 25 | $108.0K | $21.7M | ||
| Q1 25 | $-125.0K | $7.8M | ||
| Q4 24 | $2.0M | $58.5M | ||
| Q3 24 | $13.2M | $24.5M | ||
| Q2 24 | $6.2M | $11.7M | ||
| Q1 24 | $4.0M | $4.8M |
自由现金流CTKBRBB
| Q4 25 | $-1.8M | $42.6M | ||
| Q3 25 | $-4.6M | $1.8M | ||
| Q2 25 | $-1.5M | $21.6M | ||
| Q1 25 | $-974.0K | $7.6M | ||
| Q4 24 | $1.1M | $57.7M | ||
| Q3 24 | $12.2M | $24.2M | ||
| Q2 24 | $5.2M | $11.5M | ||
| Q1 24 | $3.4M | $4.7M |
自由现金流率CTKBRBB
| Q4 25 | -2.9% | 131.8% | ||
| Q3 25 | -8.7% | 5.4% | ||
| Q2 25 | -3.2% | 60.2% | ||
| Q1 25 | -2.3% | 26.7% | ||
| Q4 24 | 1.9% | 201.0% | ||
| Q3 24 | 23.7% | 80.0% | ||
| Q2 24 | 11.0% | 42.0% | ||
| Q1 24 | 7.6% | 16.6% |
资本支出强度CTKBRBB
| Q4 25 | 1.6% | 2.5% | ||
| Q3 25 | 1.3% | 1.1% | ||
| Q2 25 | 3.5% | 0.3% | ||
| Q1 25 | 2.0% | 0.6% | ||
| Q4 24 | 1.6% | 2.7% | ||
| Q3 24 | 2.0% | 0.8% | ||
| Q2 24 | 2.3% | 0.5% | ||
| Q1 24 | 1.3% | 0.5% |
现金转化率CTKBRBB
| Q4 25 | — | 4.26× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 2.32× | ||
| Q1 25 | — | 3.39× | ||
| Q4 24 | 0.21× | 13.34× | ||
| Q3 24 | 14.05× | 3.50× | ||
| Q2 24 | — | 1.61× | ||
| Q1 24 | — | 0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
RBB
暂无分部数据
